The Auditory Review · For Clinicians
Peer-reviewed research moves fast. Clinic time is short. The Auditory Review exists in the gap between the two — publishing long-form science and medicine writing on hearing, auditory neuroscience, and the listening brain, for clinicians who want more than an abstract and a conclusion.
Conditions like hidden hearing loss, cochlear synaptopathy, and auditory processing disorder are under-discussed in standard clinical training. Our articles trace the science behind what patients are already describing in your consulting room — before most textbooks have caught up.
The links between auditory health and dementia, the gut microbiome, vascular function, and sleep medicine are emerging from scattered literature across several specialties. We synthesize it in one place, with enough mechanistic detail to be clinically meaningful.
Every article cites primary literature. We are transparent about the difference between animal studies, epidemiological associations, and randomized trial evidence. We do not overstate. We do not simplify away the nuance that matters for clinical decision-making.
The Auditory Review carries no advertising and accepts no sponsored content. We are editorially independent. No manufacturer, hearing aid brand, or pharmaceutical company influences what we cover or how we cover it.
We commission articles grounded in peer-reviewed research, then work with authors to ensure the science is presented accurately, the evidence is correctly characterized, and the clinical implications are neither overstated nor dismissed.
Our editorial scope is deliberately narrow. We cover hearing and auditory neuroscience in depth, rather than general medicine broadly. That focus means each piece is written by someone close to the literature — and reviewed for accuracy before publication.
The growing evidence base for cochlear synaptopathy — "hidden hearing loss" — and what it means for patients who pass audiograms but cannot function in noise. Covers the mechanisms, the clinical gap, and the state of emerging interventions.
A synthesis of the nascent gut–cochlea axis research: the blood-labyrinth barrier, inflammatory pathways, Mendelian randomization evidence linking gut bacteria to sensorineural hearing loss, and what is and isn't yet established. Frontier science, carefully framed.
The Lancet Commission evidence, the ACHIEVE trial results, the three proposed causal mechanisms, and a frank assessment of what intervention can and cannot do. Covers the clinical conversation — why patients resist hearing aids and how to address it.